
This phase 2 study was designed to assess the efficacy of single agent zzso zzso and gain further information about associated zzso and zzso in children, zzso and young adults with zzso or zzso solid zzso 

Patients with relapsed or zzso solid tumors were treated with 9 zzso of zzso as a zzso IV infusion once zzso zzso zzso zzso Ewing zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso and zzso zzso studies in zzso patients included an assessment of zzso zzso IGF-1, zzso zzso and insulin in zzso zzso 

One hundred zzso patients with 114 eligible having a median age of 12 years zzso zzso were zzso Five patients achieved a partial response: zzso with zzso zzso only) and zzso with zzso Fourteen patients had stable disease for a median of 10 zzso Hematologic and zzso zzso were generally mild and zzso zzso IGF-1 and zzso increased in response to therapy with zzso 

zzso is well tolerated in children with zzso solid zzso Limited objective zzso activity of zzso was zzso however, prolonged stable disease was observed in zzso of zzso zzso studies are evaluating the toxicity and benefit of zzso in combination with other agents that inhibit the zzso zzso 

